Carole Ho

Insider Reports History

Entity
Individual
Location
C/O Denali Therapeutics Inc., 151 Oyster Point Blvd., 2 Nd Floor, South San Francisco, CA
Signature
/s/ Tyler Nielsen, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carole Ho:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Denali Therapeutics Inc. Chief Medical Officer Common Stock 119K $2.97M $24.96 Aug 21, 2024 Direct
Denali Therapeutics Inc. Chief Medical Officer Common Stock 25K $624K $24.96 Aug 20, 2024 Indirect
Beam Therapeutics Inc. Director Stock Option (Right to Buy) 23.1K $564K $24.40 Jun 5, 2024 Direct
Denali Therapeutics Inc. Chief Medical Officer Stock Option (right to buy) 161K Jan 3, 2024 Direct
NGM BIOPHARMACEUTICALS INC Director Stock Option (Right to Buy) 0 Apr 5, 2024 Direct

Insider Reports Filed by Carole Ho

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DNLI Denali Therapeutics Inc. Aug 20, 2024 3 -$550K 4 Aug 22, 2024 Chief Medical Officer
DNLI Denali Therapeutics Inc. Aug 13, 2024 1 -$53.5K 4 Aug 15, 2024 Chief Medical Officer
BEAM Beam Therapeutics Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
NGM NGM BIOPHARMACEUTICALS INC Apr 5, 2024 4 $0 4 Apr 8, 2024 Director
DNLI Denali Therapeutics Inc. Feb 13, 2024 2 -$73.1K 4 Feb 15, 2024 Chief Medical Officer
DNLI Denali Therapeutics Inc. Jan 10, 2024 1 -$88.8K 4 Jan 12, 2024 Chief Medical Officer
DNLI Denali Therapeutics Inc. Jan 5, 2024 1 -$194K 4 Jan 9, 2024 Chief Medical Officer
DNLI Denali Therapeutics Inc. Jan 3, 2024 2 $0 4 Jan 5, 2024 Chief Medical Officer
DNLI Denali Therapeutics Inc. Aug 23, 2023 1 -$58.6K 4 Aug 25, 2023 Chief Medical Officer
DNLI Denali Therapeutics Inc. Aug 21, 2023 1 -$56K 4 Aug 23, 2023 Chief Medical Officer
DNLI Denali Therapeutics Inc. Aug 14, 2023 1 -$65.9K 4 Aug 16, 2023 Chief Medical Officer
DNLI Denali Therapeutics Inc. Aug 10, 2023 1 -$69K 4 Aug 14, 2023 Chief Medical Officer
BEAM Beam Therapeutics Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
NGM NGM BIOPHARMACEUTICALS INC May 10, 2023 1 $0 4 May 12, 2023 Director
DNLI Denali Therapeutics Inc. Feb 15, 2023 1 -$43.4K 4 Feb 17, 2023 Chief Medical Officer
DNLI Denali Therapeutics Inc. Feb 10, 2023 2 -$101K 4 Feb 14, 2023 Chief Medical Officer
DNLI Denali Therapeutics Inc. Feb 8, 2023 1 -$47K 4 Feb 10, 2023 Chief Medical Officer
DNLI Denali Therapeutics Inc. Jan 9, 2023 1 -$41.6K 4 Jan 10, 2023 Chief Medical Officer
DNLI Denali Therapeutics Inc. Jan 5, 2023 2 -$117K 4 Jan 9, 2023 Chief Medical Officer
DNLI Denali Therapeutics Inc. Jan 3, 2023 3 -$83.6K 4 Jan 5, 2023 Chief Medical Officer
BEAM Beam Therapeutics Inc. Sep 1, 2022 1 $0 4 Sep 2, 2022 Director
DNLI Denali Therapeutics Inc. Aug 23, 2022 1 -$77.5K 4 Aug 25, 2022 Chief Medical Officer
DNLI Denali Therapeutics Inc. Aug 19, 2022 1 -$85.6K 4 Aug 23, 2022 Chief Medical Officer
DNLI Denali Therapeutics Inc. Aug 9, 2022 1 $0 4 Aug 11, 2022 Chief Medical Officer
NGM NGM BIOPHARMACEUTICALS INC May 18, 2022 1 $0 4 May 20, 2022 Director
DNLI Denali Therapeutics Inc. Feb 11, 2022 1 -$101K 4 Feb 15, 2022 Chief Medical Officer
DNLI Denali Therapeutics Inc. Feb 9, 2022 1 -$52.8K 4 Feb 11, 2022 Chief Medical Officer
DNLI Denali Therapeutics Inc. Jan 5, 2022 1 -$127K 4 Jan 7, 2022 Chief Medical Officer
DNLI Denali Therapeutics Inc. Jan 3, 2022 2 $0 4 Jan 5, 2022 Chief Medical Officer
DNLI Denali Therapeutics Inc. Dec 6, 2021 1 -$62.8K 4 Dec 8, 2021 Chief Medical Officer
DNLI Denali Therapeutics Inc. Aug 23, 2021 1 -$300K 4 Aug 25, 2021 Chief Medical Officer
DNLI Denali Therapeutics Inc. Aug 19, 2021 2 -$126K 4 Aug 23, 2021 Chief Medical Officer
BEAM Beam Therapeutics Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director
NGM NGM BIOPHARMACEUTICALS INC Jun 8, 2021 1 $0 4 Jun 10, 2021 Director